Dr Susan Hopkins

Job title

Consultant in infectious diseases amd microbiology
Healthcare epidemiologist
Honorary senior lecturer

Qualifications

BA MB BCh BAO MSc FRCPI FRCP

GMC Number

6087440

Contact details

Phone number: 020 7794 0500

PA/secretary phone number: 020 7830 2648 x36285

PA/secretary email address: ozlem.mersin@nhs.net

Related services

Infectious diseases, Tuberculosis

Biography

Dr Hopkins is an infectious diseases and microbiology with a special interest in chronic bone and joint infections, out-patient parenteral antimicrobial therapy, antimicrobial stewardship and hospital epidemiology.  She is chair of the English Surveillance Programme for antimicrobial usage and resistance and chair of the Royal College of Physicians Healthcare associated infections working group.
 

Publications

  • Campylobacter jejuni cellulitis in a patient with pan-hypogammaglobulinaemia. Hopkins S, Abuzakouk M, Brannigan E, Bergin C, Feighery C, BMJ Case Rep. 2011 Feb 2;2011. pii: bcr0220102741. doi: 10.1136/bcr.02.2010.2741.
  • Detection and identification of bacteria in clinical samples by 16S rRNA gene sequencing: comparison of two different approaches in clinical practice. Jenkins C, Ling CL, Ciesielczuk HL, Lockwood J, Hopkins S, McHugh TD, Gillespie SH, Kibbler CC. J Med Microbiol. 2012 Apr;61(Pt 4):483-8.
  • Fortuitous vasculitis. Sharma H, Keshavan A, Little MA, Cross J, Lipman MC, Talukdar S, Hopkins S.Ren Fail. 2012;34(3):378-82.
  • Neonatal sepsis - many blood samples, few positive cultures: implications for improving antibiotic prescribing. Blackburn RM, Muller-Pebody B, Planche T, Johnson A, Hopkins S, Sharland M, Kennea N, Heath PT. Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F487-8.
  • The European Centre for Disease Prevention and Control (ECDC) Pilot Point Prevalence Survey of Healthcare-associated infections and antimicrobial use. P Zarb1,2, B Coignard3, J Griskeviciene4, A Muller2, V Vankerckhoven2 K Weist, M M Goossens, S Vaerenberg5, S Hopkins6, B Catry5, D L Monnet4, H Goossens, C Suetens, National Contact Points for the ECDC pilot point prevalence survey7, Hospital Contact Points for the ECDC pilot point prevalence survey7. Eurosurveillance; 17, (46) 15 November 2012
  • Sequencing and phylogenetic characterisation of a fatal Crimean - Congo haemorrhagic fever case imported into the United Kingdom, October 2012. Atkinson B, Latham J, Chamberlain J, Logue C, O'Donoghue L, Osborne J, Carson G, Brooks T,Carroll M, Jacobs M, Hopkins S, Hewson R.Euro Surveill. 2012 Nov 29;17(48). pii: 20327.
  • Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial. Thwaites G, Auckland C, Barlow G, Cunningham R, Davies G, Edgeworth J, Greig J, Hopkins S,Jeyaratnam D, Jenkins N, Llewelyn M, Meisner S, Nsutebu E, Planche T, Read RC, Scarborough M, Soares M, Tilley R, Török ME, Williams J, Wilson P, Wyllie S, Walker AS; on behalf of the United Kingdom Clinical Infection Research Group. Trials. 2012 Dec 18;13(1):241.
  • No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. Singh R, Marshall N, Smith CJ, Reynolds CJ, Breen RA, Bhagani S, Cropley I, Hopkins S,Swaden L, Johnson MA, Lipman MC. AIDS. 2013 Jan 28;27(3):481-4. doi: 10.1097/QAD.0b013e32835a67fb.
  • Tuberculosis in London: not unexpected.Anderson C, Hopkins S, Adeboyeku D, Maguire H.Lancet. 2013 Jan 19;381(9862):201. doi: 10.1016/S0140-6736(13)60084-7.
  • Ribotyping in the detection of Clostridium difficile outbreaks in a single university hospital. Patel TA, Smith R, Hopkins S. J Hosp Infect. 2013 Jan;83(1):77-9. doi: 10.1016/j.jhin.2012.09.018. Epub 2012 Nov 14.
  • Improving antimicrobial stewardship and surveillance: the Chennai Declaration.Hopkins S. BMJ. 2013 Jan 28;346:f591. doi: 10.1136/bmj.f591.
  • Targeted versus universal screening and decolonization to reduce healthcare-associated meticillin-resistant Staphylococcus aureus infection Q1. S.R. Deeny, B.S. Cooper, B. Cookson, S. Hopkins, J.V. Robotham J Hosp Inf 2013; 85(1):33-44
  • Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context. Hope R; Blackburn R; Verlander N; Johnson A; Kearns A; Hill R; Hopkins S; Sheridan E; Livermore, D. M. J Antimicrob Chemother. 2013 Nov;68(11):2641-7.
  • Evaluation of a national microbiological surveillance system to inform automated outbreak detection. Freeman R, Charlett A, Hopkins S, O'Connell AM, Andrews N, Freed J, Holmes A, Catchpole M. J Infect. 2013 Jul 20. doi:pii: S0163-4453(13)00206-5. 10.1016/j.jinf.2013.07.021
  • The National One Week Prevalence Audit of Universal Meticillin Resistant Staphylococcus aureus (MRSA) Admission Screening 2012. C Fuller, J Robotham, J Savage, S. Hopkins, S Deeny, S Stone, B Cookson. PLoS One. 2013 Sep 12;8(9):e74219.
  • Managing latent tuberculosis in UK renal transplant units:how does practice compare with published guidance. Maynard-Smith L, Fernando B, Hopkins S, Harber M, Lipman. Clin Med 2014; 14(1):26-9
  • First confirmed case of Crimean-Congo haemorrhagic fever in the UK.Barr DA, Aitken C, Bell DJ, Brown CS, Cropley I, Dawood N, Hopkins S, Jacobs M, Jeffs B, MacConnachie A, Mulvaney DW, Nicol E, Fox R. Lancet. 2013 Oct 26;382(9902):1458. doi: 10.1016/S0140-6736(13)61718-3
  • Utility and limitations of Spa-typing in understanding the epidemiology of staphylococcus aureus bacteraemia isolates in a single University Hospital. Satta G, Ling CL, Cunningham ES, McHugh TD, Hopkins S.BMC Res Notes. 2013 Oct 2;6:398. doi: 10.1186/1756-0500-6-398.
  • Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required? Melchionda V, Wyatt H, Capocci S, Garcia Medina R, Solamalai A, Katiri S, Hopkins S, Cropley I, Lipman M.Eur Respir J. 2013 Oct;42(4):1148-50
  • Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR). Ashiru-Oredope D, Hopkins S; English Surveillance Programme for Antimicrobial Utilization and Resistance Oversight Group. J Antimicrob Chemother. 2013 Nov;68(11):2421-3.
  • Do we need bacteriological confirmation of cure in uncomplicated tuberculosis? Leahy AU, Lipman M, Hetzel M, Kon OM, Hopkins S, Abubakar I. Eur Respir J. 2013 Sep;42(3):860-3.
  • A prospective study comparing contamination rates between a novel mid-stream urine collection device (Peezy) and a standard method in renal patients. Collier S, Matjiu F, Jones G, Harber M, Hopkins S. J Clin Pathol. 2014 Feb;67(2):139-42
  • Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies. Kaasch AJ, Barlow G, Edgeworth JD, Fowler VG Jr, Hellmich M, Hopkins S, Kern WV, Llewelyn MJ, Rieg S, Rodriguez-Baño J, Scarborough M, Seifert H, Soriano A, Tilley R, Tőrők ME, Weiß V, Wilson AP, Thwaites GE; ISAC, INSTINCT, SABG, UKCIRG, and Colleagues. J Infect. 2014 Mar;68(3):242-51. doi: 10.1016/j.jinf.2013.10.015. Epub 2013 Nov 16.